Navigation Links
Insmed Announces First Quarter 2009 Financial Results
Date:5/13/2009

RICHMOND, Va., May 13 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2009.

Recent Company Highlights

  • Follow-on Biologics Program
    • Finalized sale of follow-on biologics (FOB) assets to Merck & Co., Inc., through an affiliate, for gross proceeds of $130 million; and
    • Net of finance and legal fees paid, Insmed has received net proceeds to date of approximately $128 million as a result of this agreement. Taxes due on the sale will be paid by installment during the balance of the year, resulting in total expected net proceeds of approximately $125 million.

  • IPLEX(TM)
    • Continue to expect preliminary Phase 2 data in Myotonic Muscular Dystrophy (MMD) in the second quarter of 2009;
    • The FDA announced that it would allow Insmed to provide access to IPLEX(TM) for investigational use in patients with Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease). Insmed will conduct a controlled clinical trial under an Investigational New Drug application;
    • Announced the signing of an agreement with IDIS, a private, UK-based company specializing in the management of medicines on a named patient basis, also known as expanded access programs (EAPs) or named patient programs (NPPs), to manage such programs for IPLEX(TM) worldwide, excluding the U.S. and Italy; and
    • Generated $2.0 million in cost recovery revenue from the IPLEX(TM) EAP for ALS in Italy during the first quarter of 2009.

  • Corporate'/>"/>

SOURCE Insmed Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... $500,000 to prevent crop damage by nematodes as the Divergence ... ... (PRWEB) February 9, 2010 -- Divergence, Inc. ... Business Innovation Research (SBIR) grants totaling $500,000, along with renewed ... advancement of the company’s innovative work to prevent crop damage ...
(Date:2/9/2010)... HUNTINGTON BEACH, California and AMSTERDAM , ... leader in molecular cancer diagnostics, announced today that,it ... New York State ,Department of Health. The ... company to receive,commercial samples of MammaPrint, its FDA-cleared ... With this latest permit, Agendia has now obtained ...
(Date:2/9/2010)... 9 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc.,(NYSE Amex: ... company with operations in the U.S. and ... network has expanded into the southwestern,region of the ... at Westlake,Orthopaedics Spine & Sports ("Westlake") in ... to achieve its target of 10 collection centers ...
(Date:2/8/2010)... The Netherlands , February 8 ... Standard: QIA) today announced that its wholly,owned subsidiary ... for,biomarker PI3K from Johns Hopkins University ... shown that variation in the PI3K gene could,be ... diagnostic with certain cancer,treatments. The studies suggest that ...
Breaking Biology Technology:New Funding Validates Importance of Divergence's Work on Nematodes 2New Funding Validates Importance of Divergence's Work on Nematodes 3Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 2Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 3Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network 4QIAGEN Acquires Exclusive Licence for Key PI3K gene 2QIAGEN Acquires Exclusive Licence for Key PI3K gene 3QIAGEN Acquires Exclusive Licence for Key PI3K gene 4
... Consejo Superior de Investigaciones Cientficas (CSIC) has reproduced the ... the smallest molecular system that exists. In 1803 the ... from a distant source, on passing through a double ... theory that light had wave motion properties. The authors ...
... Nov. 15 /PRNewswire-FirstCall/ - Helix BioPharma Corp.,(TSX, FSE: ... Segal and,John Docherty. Effective immediately, the joint role ... Dr. Segal will be separated whereby,Dr. Segal will ... will assume the role of President. "These ...
... With its warm business climate,and appealing lifestyle, Florida ... states. Statewide, Florida,s high-tech industries added 10,900 ... jobs, according to Florida Cybercities,2007, a recent report ... current state data available. With a 4 ...
Other Biology Technology:Young's experiment in a hydrogen molecule 2Helix BioPharma Corp. announces management changes 2Florida's Technology Sector Attracting Skilled Workers Needing Homes 2
(Date:2/9/2010)... Neurological Institute at St. Joseph,s Hospital and Medical ... of a new category of painkillers, called TRPV1 ... receptor potential vannilloid-1 (TRPV1) channel, which is the ... from hot peppers. However, clinical trials have revealed ... rise in body temperature. , Research has shown ...
(Date:2/9/2010)... long been a model system for studying and understanding ... viruses that cause influenza, measles and rabies. ... the potential to be genetically modified to serve as ... cells while sparing healthy cells, and as a potent ... to occur, however, scientists must have an accurate picture ...
(Date:2/9/2010)... Feb. 9 Fujitsu Frontech ... innovative computer products including peripherals, biometric security solutions ... luxurious new Fairmont Pacific Rim hotel ... using the new Fujitsu WT-A511 UHF-Band RFID (Radio ... inventory of 10,000 employee uniforms and 25,000 bathrobes, ...
Breaking Biology News(10 mins):New era of pain drugs advanced by Barrow researcher 2Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV 2New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 2New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 3New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 4New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring 5Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 1Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 2Webcast Alert 3A Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call 52501 1Webcast Alert 3A Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call 52501 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 1Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 3
... Aware, Inc. (Nasdaq: AWRE ), a leading ... the preliminary results of its modified Dutch Auction tender ... time, on Friday, April 17, 2009.In accordance with the ... on the preliminary count by Computershare Trust Company, N.A., ...
... just proven that one of Bob Dylan,s most famous ... discovered that the brain manufactures proteins that act like ... discovery, published online in The FASEB Journal ... for managing pain, stimulating appetite, and preventing marijuana abuse. ...
... early April, Adam Wilson posted a status update on ... thinking about it. , Just 23 characters long, his ... manageable way in which "locked-in" patients can couple brain-computer ... of Wisconsin-Madison biomedical engineering doctoral student, Wilson is among ...
Other Biology News:Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer 2Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer 3Researchers use brain interface to post to Twitter 2Researchers use brain interface to post to Twitter 3
... Plus Array CGH Genomic Labeling Systems are ... labeling of genomic DNA samples for array-based ... indirect and direct labeling formats, the BioPrime ... a flexible solution to your genomic labeling ...
... bioassays for interferons are cytopathic effect inhibition assays, ... Sample types include; tissue culture supernatents; serum from ... assays, one unit is defined as the quantity ... cytopathic effect of viral infection by 50%. ...
... for interferons are cytopathic effect inhibition assays, also ... types include; tissue culture supernatents; serum from PK ... one unit is defined as the quantity of ... effect of viral infection by 50%. ...
Request Info...
Biology Products: